May 7 |
Windtree Therapeutics regains compliance with Nasdaq, shares up
|
May 7 |
Windtree Therapeutics Regains Compliance with Nasdaq
|
Apr 23 |
(WINT) - Analyzing Windtree Therapeutics's Short Interest
|
Apr 18 |
Windtree Therapeutics approves reverse stock split
|
Apr 18 |
Windtree Therapeutics Announces Reverse Stock Split
|
Apr 17 |
Windtree Therapeutics GAAP EPS of -$0.95
|
Apr 17 |
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
|
Apr 8 |
Windtree to buy certain assets of Varian Biopharmaceuticals
|
Apr 8 |
Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing
|
Feb 14 |
Windtree Therapeutics files to sell 608,272 shares for holders
|